Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Generic enzyme 9b
[{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9ec/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9ec/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9eb/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9eb/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9ea/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9ea/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9e9/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9e9/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9e8/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9e8/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9e7/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9e7/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9e6/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9e6/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9e5/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9e5/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9e4/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9e4/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9e3/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9e3/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9e2/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9e2/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9e1/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9e1/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9e0/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9e0/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9df/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9df/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9de/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9de/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9dd/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9dd/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9dc/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9dc/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9db/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9db/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9da/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9da/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9d9/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9d9/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9d8/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9d8/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9d7/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9d7/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9d6/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9d6/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9d5/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9d5/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9d4/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9d4/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9d3/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9d3/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9d2/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9d2/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9d1/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9d1/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9d0/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9d0/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9cf/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9cf/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9ce/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9ce/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9cd/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9cd/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9cc/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9cc/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9cb/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9cb/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9ca/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9ca/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9c9/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9c9/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9c8/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9c8/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9c7/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9c7/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9c6/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9c6/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9c5/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9c5/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9c4/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9c4/5d2ce370f02f730400c4f9c2.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce3b8f02f730400c4f9c3/5d2ce370f02f730400c4f9c2.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce3b8f02f730400c4f9c3/5d2ce370f02f730400c4f9c2.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
receptor,ligand,target ligand,targeting ligand,targeted ligand,protein,pathway,signaling,cascade,diagram,transcription factor,generic,catalyst,enzyme,substrate,lock and key
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
